News und Analysen
Is Target Stock's High Yield Worth It in 2025?
With volatility returning to the markets this year, safer dividend stocks with high yields are looking more attractive. Target (NYSE: TGT) stands out as a potential investment option, largely
3 High-Yielding Dividend Stocks That Should Pay You Forever
Holding shares of strong companies that pay consistent dividends can help you preserve and grow your savings. Three Motley Fool contributors recently selected their favorite high-yield dividend
Chow Tai Fook Jewellery Appoints David Tse as Global Creative Director
CarMax Reports Third Quarter Fiscal Year 2026 Results
CarMax, Inc. (NYSE:KMX) today reported results for the third quarter ended November 30, 2025.
Third Quarter Highlights:(1)
-
Announced leadership changes effective December 1, 2025. Member of
Carmax Announces Third Quarter Conference Call
CarMax, Inc. (NYSE:KMX) will report its financial results for the third quarter ended November 30, 2025 before the market opens on December 18, 2025, and it will host a conference call with
Chow Tai Fook Jewellery Reports Solid Recovery Trajectory in 1HFY2026 Underpinned by Strong Margins and Steady Progress in Brand Transformation
Copart Reports First Quarter Fiscal 2026 Financial Results
Copart, Inc. (NASDAQ: CPRT) today reported financial results for the quarter ended October 31, 2025.
For the three months ended October 31, 2025, revenue, gross profit, and net income
Copart, Inc. to Release First Quarter Fiscal 2026 Results
Copart, Inc. (NASDAQ: CPRT) announced today that it will release earnings for the first quarter of fiscal 2026 after 4:00 p.m. Eastern Time (3:00 p.m. Central) on Thursday, November 20, 2025.
On
CarMax Announces Leadership Changes
CarMax, Inc. (NYSE: KMX) (“CarMax” or the “Company”) today announced leadership changes to strengthen its business. David McCreight, a member of the Board of Directors (the “Board”), and proven
CarMax Reports Second Quarter Fiscal Year 2026 Results
CarMax, Inc. (NYSE:KMX) today reported results for the second quarter ended August 31, 2025.
Second Quarter Highlights:(1)
-
Retail used unit sales decreased 5.4% and comparable store used
CarMax Announces Second Quarter Conference Call
CarMax, Inc. (NYSE:KMX) will report its financial results for the second quarter ended August 31, 2025 before the market opens on September 25, 2025, and it will host a conference call with
Copart Reports Fourth Quarter Fiscal 2025 Financial Results
Copart, Inc. (NASDAQ: CPRT) today reported financial results for the quarter and year ended July 31, 2025.
For the three months ended July 31, 2025, revenue, gross profit, and net income
CarMax Reports First Quarter Fiscal Year 2026 Results
CarMax, Inc. (NYSE:KMX) today reported results for the first quarter ended May 31, 2025.
First Quarter Highlights:(1)
-
Net earnings per diluted share increased 42.3% to $1.38 from $0.97 a
CarMax Announces First Quarter Conference Call and Annual Meeting Information
CarMax, Inc. (NYSE:KMX) will report its financial results for the first quarter ended May 31, 2025 before the market opens on June 20, 2025, and it will host a conference call with investors at
Copart Reports Third Quarter Fiscal 2025 Financial Results
Copart, Inc. (NASDAQ: CPRT) today reported financial results for the quarter ended April 30, 2025.
For the three months ended April 30, 2025, revenue, gross profit, and net income attributable to
Advance Auto Parts Reports First Quarter 2025 Results and Reaffirms Full Year Guidance
Advance Auto Parts, Inc. (NYSE: AAP), a leading automotive aftermarket parts provider in North America that serves both professional installer and do-it-yourself customers, announced its financial
Copart, Inc. to Release Third Quarter Fiscal 2025 Results
Copart, Inc. (NASDAQ: CPRT) announced today that it will release earnings for the third quarter of fiscal 2025 after 4:00 p.m. Eastern Time (3:00 p.m. Central) on Thursday, May 22, 2025.
On
Advance Auto Parts Announces Date for First Quarter 2025 Earnings Release and Conference Call
Advance Auto Parts, Inc. (NYSE: AAP), a leading automotive aftermarket parts provider in North America that serves both professional installers and do-it-yourself customers, will report financial
Vanguard Mining Surpasses 500 Metres in Ongoing Drill Program at the Redonda Copper-Molybdenum Project, British Columbia
Vancouver, BC – November 21, 2025 – Vanguard Mining Corp. ("Vanguard" or the "Company") (CSE: UUU | OTC: UUUFF | Frankfurt: SL51) is pleased to announce drilling has now surpassed 500 metres
Weltweiter Wettlauf um Seltene Erden. Neue Achse für westliche Unabhängigkeit von Chinas Rohstoffmacht
Weltweiter Wettlauf um Seltene Erden. Neue Achse für westliche Unabhängigkeit von Chinas Rohstoffmacht
17.11.25 08:03
Toronto (www.aktiencheck.de)
Dies ist eine
Vanguard Mining Commences 2025 Diamond Drill Program at Redonda Copper-Molybdenum Project, British Columbia
Vancouver, BC – November 7th, 2025 – Vanguard Mining Corp. ("Vanguard" or the "Company") (CSE: UUU | OTC: UUUFF | Frankfurt: SL51) is pleased to announce that it has commenced its 2025
GA-ASI and Hanwha Finalize Deal To Produce Gray Eagle(R) STOL UAS
Partnership Will Enable Cost Savings By Manufacturing Unique and Flexible UAS Platform in South Korea
SAN DIEGO, CA / ACCESS Newswire / October 14, 2025 / General Atomics Aeronautical
Ridgeline Minerals Provides Assay Results and Drill Program Updates for the Big Blue and Atlas Projects
Big Blue highlights: 0.6 meters grading 0.7% Cu, 3,194 g/t Ag and 2.6% W (or 35.3% CuEq)
To view a summary of today’s press release by Ridgeline CEO Chad Peters, click HERE
Vancouver, C
Klondike Gold Completes Phase 1 Exploration Program
June 17, 2025, Vancouver, British Columbia, Canada – Klondike Gold Corp. (TSX.V: KG; FRA: LBDP; OTCQB: KDKGF) (“Klondike Gold” or the “Company”) is pleased to announce the completion of
OBI Pharma kündigt zehn Posterpräsentationen auf der AACR-Jahrestagung 2026 zu den glykanbasierten, ortsspezifischen Antikörper-Wirkstoff-Konjugaten (ADCs) GlycOBI(R) an:
OBI Pharma kündigt zehn Posterpräsentationen auf der AACR-Jahrestagung 2026 zu den glykanbasierten, ortsspezifischen Antikörper-Wirkstoff-Konjugaten (ADCs) GlycOBI(R) an: mono- und




